TPG Biotech is the life sciences venture capital platform of TPG, a leading global alternative asset manager. See sector focus and contact routes.
TPG Biotech is the life sciences venture capital platform of TPG, a leading global alternative asset manager, established in 2002 to invest in pharmaceutical discovery, medical technology, diagnostics, and biotechnology applications. The firm pursues a thematic investment thesis concentrating on oncology, autoimmune and inflammatory diseases, cardiometabolic conditions, ophthalmology, rare diseases, and commercial-stage medical devices or tech-enabled services. It partners with companies from early-stage development through clinical trials to commercialization, leveraging deep scientific, clinical, and operational expertise. While the search results confirm TPG Biotech operates as a life science venture capital firm investing globally in therapeutics, medical devices, and healthcare services, they do not specify typical check sizes or whether the firm acts as a lead or follow investor. The available sources do not list any specific named portfolio companies for TPG Biotech. Additionally, no distinctive point of view, public writing, or unique investment philosophy beyond its thematic sector focus is documented in the provided results.
This profile is part of the StartupFundraising firm database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find comparable investors.
Investors like TPG Biotech · Full investor directory · Investor access · Company funding database